Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Mangata Networks Forges Strategic Collaboration with Microsoft to Pioneer AI-Enabled Edge Cloud Connectivity via Satellite




Partnership will advance the reach and functionality of Microsoft Azure cloud, through global, high-speed low latency satellite connectivity and advanced edge compute solutions.

PHOENIX, Dec. 22, 2023 /PRNewswire/ — Mangata Networks, a global company offering satellite-enabled connectivity & intelligent edge computing solutions, has signed a partnership with Microsoft aimed at developing an AI-enabled edge cloud product connected via satellite. This partnership represents a long-term commitment between Mangata Networks and Microsoft, marking the beginning of a sustained collaborative journey aimed at continuously advancing cloud technology through innovative satellite connectivity.

Partnership Accelerates Azure Adaptive Cloud Adoption

Mangata will provide seamless connectivity and intelligent cloud computing services around the globe, bringing the benefits of Azure innovation anywhere in the world.

The network is powered by a multi-orbit constellation of HEO (highly elliptical orbit) and MEO (medium Earth orbit) satellites and a terrestrial network of edge data centers.

“We are thrilled to develop this transformative product in strategic collaboration with Microsoft, further enriching the Microsoft commercial marketplace ecosystem. Microsoft’s direct sales channels will play a crucial role in scaling our innovative solutions to enterprises globally. Our offering is not just a product but an all-encompassing network, infrastructure, platform, and software service.  With capacity bundled into the service, we provide a seamless, integrated SLA that simplifies the adoption of our services for customers.” said Brian Holz, CEO of Mangata Networks. “This is more than a partnership; it is a long-term alliance set to redefine how enterprises leverage the cloud and intelligent edge compute.”

Innovative Features and SLAs Redefining Edge Cloud Connectivity and Business Transformation

A core element of the partnership is a deep commitment to innovation, where Mangata Networks will collaborate with Microsoft and execute against an integrated Edge-to-Space-to-Cloud product roadmap.

Leveraging Microsoft’s generative AI and data analytics capabilities, Mangata will, in close collaboration with Microsoft, re-imagine the entire product innovation lifecycle. These efforts will include integrating AI capabilities end-to-end; from customer and partner feedback and requirements definition through to how we roadmap, create, code, test, deploy, run, and support customer solutions. This initiative will result in delivering Azure adaptive cloud solutions, specifically designed to address unique and complex business problems at the edge, enabling and accelerating customer outcomes in a culturally sensitive way.

Mangata’s managed service will extend the geographical reach and functionality of Azure adaptive cloud. These collaborative solutions will deliver an array of innovative features, including AI-enhanced network routing at the edge, remote bandwidth optimization, workload management, real-time data processing, digital twin support, advanced satellite backhaul management, end-to-end cloud-edge IoT applications, 5G integration standardization, and multivendor sub-system integration (for example, ORAN and RAN-based equipment).

The Mangata and Microsoft solution using Azure will be made available through the Azure Marketplace, offering end-to-end application-level Service Level Agreements (SLA) with bundled connectivity. This comprehensive approach ensures a seamless experience for users seeking advanced and integrated solutions. Under the terms of the agreement, Microsoft will position Mangata as an Independent Software Vendor (ISV) on the Azure platform. This move will empower Mangata’s growth trajectory, with Microsoft providing substantial support in terms of technology, resources, engineering, as well as go-to-market backing.

Processing Data at the Best Location

With powerful edge compute and data management capabilities, customers can process data where it is created, reducing latency and time-to-insight by hosting advanced analytics and AI-inferencing at the edge. Valuable data, previously discarded due to lack of available bandwidth, can now be sent to cloud services like Microsoft Fabric, an end-to-end, unified analytics platform that brings together all the data and analytics tools organizations need -where it can be used to train and retrain AI models- to yield deeper operational insights.

For highly regulated organizations and governments, and for geographies with strict data sovereignty rules, applications can process sensitive data at the edge, keeping it within national or regional boundaries and only sending what is allowed to the public cloud.

“In collaboration with Mangata, we look forward to delivering an end-to-end Cloud and Edge platform to enterprise and government customers.   This platform will enable business and mission critical applications anywhere with committed availability through satellite connectivity. Mangata will leverage Microsoft’s portfolio of Microsoft Azure Space and Azure for Operators to run their satellites’ constellation and edge platform. This collaboration is key for our continued commitment to empower our customers with intelligent, secure, and resilient technology.” said Mitra Azizirad, President and Chief Operating Officer, for Growth, Innovation and Strategy, Microsoft Strategic Missions and Technologies.

Addressing Global Challenges and Closing the Digital Divide

This collaboration is set to address critical challenges on a global scale related to sovereign state requirements, enterprise innovation, maritime and digital ocean transformation, data gravity, and telecommunications access and capacity needs. Mangata’s mission to empower the exchange of knowledge through global connectivity and to revolutionize access to the digital economy aligns with the Airband Initiative, a collaboration between Microsoft and the United States Agency for International Development (USAID) focused on closing the global digital divide by bringing internet access to all.

A New Era of AI-enabled Edge Cloud Computing

The pilot phase of the pre-integrated solutions in customer trial networks is scheduled to commence in the late 2nd quarter of 2024, ahead of Mangata’s planned constellation launch.

This initiative is poised to revolutionize the way businesses and governments worldwide harness the power of edge cloud connectivity through satellite technology. Together, Microsoft and Mangata will create a new platform for highly reliable, scalable, and robust IoT and SCADA applications at the edge, all connected to and managed by Azure. The collaboration marks a significant step toward a more connected, intelligent, and accessible future. This collaboration is not just a milestone but a starting point for a long-term journey between Mangata Networks and Microsoft, where both entities are committed to a lasting partnership that evolves with technological advancements.

About Mangata

Mangata Networks is a global, satellite-enabled network services and intelligent edge computing company. Founded in February 2020, Mangata has operations in the United States, United Kingdom, Singapore, and South Korea. Mangata is backed by an international group of investors including venture capital firms, economic development groups, and strategic partners.

Powered by a multi-orbit constellation and terrestrial network of intelligent data centers, Mangata provides secure, high-speed, low-latency connectivity that is affordable and accessible to all. With AI-enabled computing at the edge of the network, our customers can access cloud applications under a unified, global, and secure system – anywhere in the world.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading